CLEAR
Biosimilars have the potential to have a positive impact on patients and the healthcare system. They can reduce costs by offering a lower-cost treatment option and provide more treatment options for patients.
Biosimilars introduce competition into the healthcare system. As the number of treatment choices increases for a particular disease or condition, manufacturers are incentivized to reduce the prices of their products to maintain or increase market share.
The competition fostered by a marketplace with biosimilars could benefit every stakeholder in the healthcare system
Opportunity for system-wide cost savings
Headroom for greater investment in innovator products
More treatment options for patients with serious illnesses
Manufacturers incentivized to reduce prices
With rising healthcare costs, biosimilars contribute to a more sustainable healthcare system by providing patients with more treatment options.5